UBS Group’s Clene CLNN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.16K | Sell |
351
-3,626
| -91% | -$22.6K | ﹤0.01% | 9390 |
|
|
2026
Q1 | $19.6K | Buy |
3,977
+1,339
| +51% | +$6.86K | ﹤0.01% | 7950 |
|
|
2025
Q4 | $15.5K | Buy |
2,638
+2,623
| +17,487% | +$21.8K | ﹤0.01% | 7957 |
|
|
2025
Q3 | $90 | Sell |
15
-1,663
| -99% | -$7.9K | ﹤0.01% | 9935 |
|
|
2025
Q2 | $6.56K | Buy |
1,678
+1,368
| +441% | +$4.46K | ﹤0.01% | 9085 |
|
|
2025
Q1 | $955 | Buy |
310
+301
| +3,344% | +$1.36K | ﹤0.01% | 9604 |
|
|
2024
Q4 | $48 | Buy |
9
+1
| +13% | +$5 | ﹤0.01% | 9709 |
|
|
2024
Q3 | $37 | Sell |
8
-638
| -99% | -$3.35K | ﹤0.01% | 9259 |
|
|
2024
Q2 | $4.6K | Buy |
646
+637
| +7,078% | +$4.77K | ﹤0.01% | 8072 |
|
|
2024
Q1 | $72 | Buy |
9
+1
| +13% | +$9 | ﹤0.01% | 8882 |
|
|
2023
Q4 | $50 | Hold |
8
| – | – | ﹤0.01% | 8994 |
|
|
2023
Q3 | $84 | Hold |
8
| – | – | ﹤0.01% | 8925 |
|
|
2023
Q2 | $149 | Hold |
8
| – | – | ﹤0.01% | 8445 |
|
|
2023
Q1 | $191 | Sell |
8
-478
| -98% | -$12.4K | ﹤0.01% | 9145 |
|
|
2022
Q4 | $9.71K | Buy |
486
+162
| +50% | +$3.76K | ﹤0.01% | 8620 |
|
|
2022
Q3 | $18K | Sell |
324
-797
| -71% | -$52.8K | ﹤0.01% | 7510 |
|
|
2022
Q2 | $56K | Buy |
1,121
+595
| +113% | +$33.2K | ﹤0.01% | 5821 |
|
|
2022
Q1 | $41K | Sell |
526
-357
| -40% | -$21.6K | ﹤0.01% | 6680 |
|
|
2021
Q4 | $73K | Buy |
883
+860
| +3,739% | +$92K | ﹤0.01% | 6571 |
|
|
2021
Q3 | $3K | Buy |
23
+19
| +475% | +$3.24K | ﹤0.01% | 8796 |
|
|
2021
Q2 | $1K | Sell |
4
-31
| -89% | -$6.53K | ﹤0.01% | 9132 |
|
|
2021
Q1 | $9K | Buy |
+35
| New | +$7.68K | ﹤0.01% | 7992 |
|
|
2020
Q4 | – | Sell |
-52
| Closed | -$11K | – | 8418 |
|
|
2020
Q3 | $11K | Sell |
52
-53
| -50% | -$11.5K | ﹤0.01% | 6751 |
|
|
2020
Q2 | $22K | Sell |
105
-125
| -54% | -$26.6K | ﹤0.01% | 6485 |
|
|
2020
Q1 | $48K | Buy |
+230
| New | +$48.3K | ﹤0.01% | 5859 |
|
|
2019
Q3 | – | Sell |
-10
| Closed | -$2K | – | 8016 |
|
|
2019
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 7606 |
|
|
2019
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 7424 |
|
|
2018
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 7793 |
|
|
2018
Q3 | $2K | Buy |
+10
| New | +$1.93K | ﹤0.01% | 7732 |
|
Other funds holding CLNN
EAM
VCM
VFT
LCM
PCM
UBS Group's CLNN Position: Q2 2026 in Review
UBS Group reduced its Clene (CLNN) stake by 91% in Q2 2026, selling an estimated $22.6K and leaving 351 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #9390.
UBS Group first reported a position in CLNN in Q3 2018 and has held it in 29 quarters since. The position peaked at $73K in Q4 2021. 21 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.
- UBS Group held 351 shares of Clene worth $2.16K as of Q2 2026.
- UBS Group sold 3,626 Clene shares in Q2 2026, an estimated $22.6K.
- Clene made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9390 holding.
- UBS Group first reported a position in Clene in Q3 2018 and has held it in 29 quarters since.
- UBS Group's Clene position peaked at $73K in Q4 2021.
- 21 funds tracked by Wall St. Rank held Clene as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.